The Biotechnology Laboratory of the International Scientific-Technological Park of the Academy of Sciences of Turkmenistan conducted a research to obtain the bioflavonoid resveratrol from the red grape variety "Late Vavilov."
Specialists isolated this valuable antioxidant from various parts of the grapevine: callus, berry skins, shoots, seeds, and pomace. The experiment also used the Terbash, Ashgabat, Taifi, Cabernet, and Garauzum varieties. Extractive phenolic compounds with high antioxidant activity were obtained from the leaves of cultivated grape varieties collected at the end of the vegetative period.
The State Intellectual Property Service of the Ministry of Finance and Economy of Turkmenistan registered the copyright for the technology of obtaining resveratrol from the "Late Vavilov" variety.
The "Late Vavilov" variety was bred at the Turkmen Experimental Station of ASRIP between 1970 and 1978 by crossing the "Ichkimar" and "Janjal Kara" varieties. This variety has large, conical clusters, and the berries are elongated-cylindrical.
Resveratrol is a powerful natural antioxidant that strengthens the cardiovascular system, protects cells from free radicals, supports memory, and, according to scientists, may prevent cancer development. The compound also has anti-aging properties by blocking the glycation process and preventing damage to collagen fibers. This helps maintain youthful and firm skin and stimulates regenerative processes in the body.
The grapevine has a unique ability to withstand frost, rain, and wind thanks to resveratrol. In addition, grapes contain polyphenols, ellagic acid, and other nutrients that, combined with vitamin C, provide powerful antioxidant support.
Altyn Rakhmanova, head of the Biotechnology Laboratory at the International Scientific-Technological Park of the Academy of Sciences of Turkmenistan, notes that the invention may find wide application in pharmacology, cosmetology, and dermatology.
The development of biotechnology plays a key role in the global economy, and achieving excellence in this field is a priority for developed countries. Turkmenistan is actively working in this direction. Within the framework of the "Strategy for the Development of the Science for 2024–2052" and the "Program for the Comprehensive Development of Biotechnology in the Country for 2024–2028," approved by the Decree of the President of Turkmenistan, specialists are conducting scientific and practical research to implement scientific achievements in various sectors of the economy. One of the significant tasks of these programs is the development of technologies for obtaining new medicines from the flora of Turkmenistan.
